Stay updated with breaking news from Dose Modification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Explore dosing nuances and adverse event management strategies for afatinib in treating EGFR mutant non-small cell lung cancer, reflecting real-world practices and clinical insights.
Rachel Layman, MD, summarizes how to dose CDK4/6 inhibitors in different clinical settings.
A panel of oncologists shares comprehensive insight to clinical trial data with tucatinib in patients with HER2+ metastatic colorectal cancer.
Singapore: Recent study by Jia Qi Yeo and team found, metabolite monitoring of thiopurine therapy against inflammatory bowel disease (IBD) enables rapid dose optimization or therapy escalation for...